Approval · Notice of Compliance 11126 · 2010
ZAVESCA: Notice of Compliance 11126
Issued March 4, 2010
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 11126
- Date
- March 4, 2010
- Company
- Actelion Pharmaceuticals LtdAllschwil, Basel-Landschaft, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: To slow the progression of some of the neurological manifestations in patients with Niemann-Pick Type C disease
- Therapeutic class
- Glucosyceramide synthase inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZAVESCA | Not yet assigned | — |
Medicinal ingredients
- MIGLUSTAT 100 MG per CAP